CDNA
Overvalued by 204.6% based on the discounted cash flow analysis.
Market cap | $473.26 Million |
---|---|
Enterprise Value | $266.12 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-3.54 |
Beta | 2.15 |
Outstanding Shares | 51,778,523 |
Avg 30 Day Volume | 687,111 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -2.49 |
---|---|
PEG | -0.46 |
Price to Sales | 1.61 |
Price to Book Ratio | 1.61 |
Enterprise Value to Revenue | 0.95 |
Enterprise Value to EBIT | -2.54 |
Enterprise Value to Net Income | -2 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.11 |
No data
No data